Coexpression of TIGIT and FCRL3 identifies a population of highly suppressive, Helios+FoxP3+ conventional Tregs [129], and several studies have described elevated surface expression of TIGIT and FCRL3 on circulating CD4+ T cells in SS [78,122,130]. This evidence concerns the gene TIGIT and synovial sarcoma.